Hamostaseologie 2010; 30(S 01): S150-S152
DOI: 10.1055/s-0037-1619099
Original article
Schattauer GmbH

Molecular analysis of FVIII gene in severe HA patients of Costa Rica

Prevalence of intron 1 and 22 inversion
L. Salazar-Sánchez
1   Centre for Research in Haematology and related disorders (CIHATA), University of Costa Rica
,
G. Jiménez-Cruz
2   Haematology Department, México Hospital, San José, Costa Rica
,
M. Mendez
1   Centre for Research in Haematology and related disorders (CIHATA), University of Costa Rica
,
P. Chaverri
2   Haematology Department, México Hospital, San José, Costa Rica
,
P. Alvarado
1   Centre for Research in Haematology and related disorders (CIHATA), University of Costa Rica
,
W. Schröder
3   Institute of Human Genetics, University Greifswald, Germany
,
K. Wulff
3   Institute of Human Genetics, University Greifswald, Germany
,
M. Sandoval
2   Haematology Department, México Hospital, San José, Costa Rica
,
F. H. Herrmann
3   Institute of Human Genetics, University Greifswald, Germany
,
A. Pavlova
4   Institute of Experimental Haematology and Transfusion Medicine, University Hospital Bonn, Germany
,
J. Oldenburg
4   Institute of Experimental Haematology and Transfusion Medicine, University Hospital Bonn, Germany
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
23. Dezember 2017 (online)

Zoom Image

Summary

Haemophilia A (HA) is X-chromosome linked bleeding disorders caused by deficiency of the coagulation factor VIII (FVIII). It is caused by FVIII gene intron 22 inversion (Inv22) in approximately 45% and by intron 1 inversion (Inv1) in 5% of the patients. Both inversions occur as a result of intrachromosomal recombination between homologous regions, in intron 1 or 22 and their extragenic copy located telomeric to the FVIII gene. The aim of this study was to analyze the presence of these mutations in 25 HA Costa Rican families. Patients, methods: We studied 34 HA patients and 110 unrelated obligate members and possible carriers for the presence of Inv22or Inv1. Standard analyses of the factor VIII gene were used incl. Southern blot and long-range polymerase chain reaction for inversion analysis. Results: We found altered Inv22 restriction profiles in 21 patients and 37 carriers. It was found type 1 and type 2 of the inversion of Inv22. During the screening for Inv1 among the HA patient, who were Inv22 negative, we did not found this mutation. Discussion: Our data highlight the importance of the analysis of Inv22 for their association with development of inhibitors in the HA patients and we are continuous searching of Inv1 mutation. This knowledge represents a step for genetic counseling and prevention of the inhibitor development.

Crossref Cited-by logo
Zitierungen